Paras Healthcare Limited
Pharmaceuticals & Healthcare • Total Issue: ₹1450 Cr
Category-Wise Subscription Breakdown
Latest snapshot as of Day 2 · Overall 0.34x
Valuation Multiples & Key Ratios
Sector Valuation Anchors & Multiples
Comparing Paras Healthcare Limited asking multiples against official 10-year historical sector norms for Pharmaceuticals & Healthcare.
“US generic price stabilization and domestic acute therapies sustaining resilient double-digit EBITDA margins.”
Grey Market Premium (GMP) History
Real-time multi-observation premium trend line and daily price movements.
IPO Timeline & Schedule
MUFG Intime India Private Limited
About Paras Healthcare Limited
Paras Healthcare operates a network of multi-specialty tertiary care hospitals under the “Paras Health” brand, primarily focused on the healthcare markets of North India and East India. The company’s core business involves providing advanced healthcare services, including complex quaternary care and specialized therapeutic treatments. It manages eight operational hospitals across cities such as Gurugram, Patna, Panchkula, Ranchi, Udaipur, Srinagar, Darbhanga, and Kanpur, with a total bed capacity of 2,211 beds as of June 30, 2026. Paras Healthcare generates the majority of its revenue from in-patient department services, which include consultations, surgeries, and specialized treatments. The company’s revenue is heavily driven by six core clinical specialties: cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and sports injury, and renal sciences. Additionally, the company generates a smaller portion of its income through in-house pharmacy sales and outpatient consultations.
Key Business Strengths
- Established “Paras Health” brand in underserved North and East India markets.
- High revenue reliance on specialized CONGOR clinical programs.
- Diversified network of eight multi-specialty hospitals with 2,211 beds.
- Advanced quaternary care supported by modern medical infrastructure.
- Improved occupancy rates and a turnaround to profitability in Fiscal 2026.
Key Risks & Challenges
- High medical staff attrition may impact care quality.
- High revenue concentration in North India poses regional risks.
- Over-reliance on CONGOR specialties risks revenue drops.
- High debt of ₹9,394.67 million strains cash flows.
- Unregistered hospital leases risk eviction and disruption.
Transparency & Informational Notice
Grey Market Premium (GMP) is unofficial, unregulated market pricing gathered from market participants and brokers. It is provided for educational and observation purposes only and does not represent guaranteed listing price or investment advice.